NFE2L2 and cancer: Conversely, the increase in DSBs in HSC2 cells with lactoferrin treatment may be due to increased ROS that promote apoptosis in the context of weakened antioxidant defenses, as lactoferrin specifically downregulates NRF2 pathway genes in cancer cells under hypoxic conditions.